These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A low-molecular-weight ferroxidase is increased in the CSF of sCJD cases: CSF ferroxidase and transferrin as diagnostic biomarkers for sCJD. Haldar S, Beveridge 'J, Wong J, Singh A, Galimberti D, Borroni B, Zhu X, Blevins J, Greenlee J, Perry G, Mukhopadhyay CK, Schmotzer C, Singh N. Antioxid Redox Signal; 2013 Nov 10; 19(14):1662-75. PubMed ID: 23379482 [Abstract] [Full Text] [Related]
4. Subtype and regional regulation of prion biomarkers in sporadic Creutzfeldt-Jakob disease. Llorens F, Zafar S, Ansoleaga B, Shafiq M, Blanco R, Carmona M, Grau-Rivera O, Nos C, Gelpí E, Del Río JA, Zerr I, Ferrer I. Neuropathol Appl Neurobiol; 2015 Aug 10; 41(5):631-45. PubMed ID: 25134744 [Abstract] [Full Text] [Related]
5. Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and Aβ42 levels. Lattanzio F, Abu-Rumeileh S, Franceschini A, Kai H, Amore G, Poggiolini I, Rossi M, Baiardi S, McGuire L, Ladogana A, Pocchiari M, Green A, Capellari S, Parchi P. Acta Neuropathol; 2017 Apr 10; 133(4):559-578. PubMed ID: 28205010 [Abstract] [Full Text] [Related]
7. Diagnostic and prognostic value of cerebrospinal fluid SNAP-25 and neurogranin in Creutzfeldt-Jakob disease in a clinical setting cohort of rapidly progressive dementias. Bentivenga GM, Baiardi S, Mastrangelo A, Zenesini C, Mammana A, Polischi B, Capellari S, Parchi P. Alzheimers Res Ther; 2023 Sep 08; 15(1):150. PubMed ID: 37684653 [Abstract] [Full Text] [Related]
8. Total and Phosphorylated Cerebrospinal Fluid Tau in the Differential Diagnosis of Sporadic Creutzfeldt-Jakob Disease and Rapidly Progressive Alzheimer's Disease. Hermann P, Haller P, Goebel S, Bunck T, Schmidt C, Wiltfang J, Zerr I. Viruses; 2022 Jan 28; 14(2):. PubMed ID: 35215868 [Abstract] [Full Text] [Related]
9. CSF Tau proteins reduce misdiagnosis of sporadic Creutzfeldt-Jakob disease suspected cases with inconclusive 14-3-3 result. Leitão MJ, Baldeiras I, Almeida MR, Ribeiro MH, Santos AC, Ribeiro M, Tomás J, Rocha S, Santana I, Oliveira CR. J Neurol; 2016 Sep 28; 263(9):1847-61. PubMed ID: 27357003 [Abstract] [Full Text] [Related]
11. Cerebrospinal Fluid Biomarkers in the Diagnosis of Creutzfeldt-Jakob Disease in Slovak Patients: over 10-Year Period Review. Koscova S, Zakova Slivarichova D, Tomeckova I, Melicherova K, Stelzer M, Janakova A, Kosorinova D, Belay G, Mitrova E. Mol Neurobiol; 2017 Oct 28; 54(8):5919-5927. PubMed ID: 27665282 [Abstract] [Full Text] [Related]
13. Diagnostic Accuracy of a Combined Analysis of Cerebrospinal Fluid t-PrP, t-tau, p-tau, and Aβ42 in the Differential Diagnosis of Creutzfeldt-Jakob Disease from Alzheimer's Disease with Emphasis on Atypical Disease Variants. Abu Rumeileh S, Lattanzio F, Stanzani Maserati M, Rizzi R, Capellari S, Parchi P. J Alzheimers Dis; 2017 Oct 28; 55(4):1471-1480. PubMed ID: 27886009 [Abstract] [Full Text] [Related]
18. The Levels of Tau Isoforms Containing Exon-2 and Exon-10 Segments Increased in the Cerebrospinal Fluids of the Patients with Sporadic Creutzfeldt-Jakob Disease. Chen C, Zhou W, Lv Y, Shi Q, Wang J, Xiao K, Chen LN, Zhang BY, Dong XP. Mol Neurobiol; 2016 Aug 13; 53(6):3999-4009. PubMed ID: 26188647 [Abstract] [Full Text] [Related]